tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Income Statement

Compare
343 Followers

Monte Rosa Therapeutics Income Statement

Last quarter (Q3 2025), Monte Rosa Therapeutics's total revenue was $12.77M, an increase of 38.54% from the same quarter last year. In Q3, Monte Rosa Therapeutics's net income was $-27.08M. See Monte Rosa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 75.62M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 67.50M$ -6.22M$ -8.56M$ 0.00$ -537.00K
Operating Expenses
$ 148.61M$ 137.09M$ 112.38M$ 72.88M$ 27.47M
Depreciation and Amortization
$ 8.12M$ 6.22M$ 3.75M$ 2.13M$ 537.00K
EBITDA
$ -72.99M$ -137.09M$ -108.64M$ -70.75M$ -27.47M
Operating Income
$ -81.11M$ -143.31M$ -112.38M$ -72.88M$ -28.01M
Other Income/Expenses
$ 10.98M$ 8.30M$ 3.88M$ -1.08M$ -7.87M
Pretax Income
$ -70.13M$ -135.01M$ -108.50M$ -73.96M$ -35.88M
Net Income
$ -72.70M$ -135.35M$ -108.50M$ -73.96M$ -35.88M
Per Share Metrics
Basic EPS
$ -0.98$ -2.63$ -2.30$ -1.59$ -0.82
Diluted EPS
$ -0.98$ -2.63$ -2.30$ -1.59$ -0.82
Weighted Average Shares Outstanding
73.91M 51.40M 47.23M 46.54M 44.00M
Weighted Average Shares Outstanding (Diluted)
73.91M 51.40M 47.23M 46.54M 44.00M
Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History